سلام بر تو ای رازی!

وبلاگ پرسنل ، محققان و بازنشستگان موسسه تحقیقات واکسن و سرم سازی رازی

درباره من
سید محمود میرافضلی
نقاشیهای دیواری موسسه رازی: باید از میان شما، جمعى دعوت به نیکى، و امر به معروف و نهى از منکر کنند! و آنها همان رستگارانند(آل عمران-104).این وبلاگ توسط این جانب سید محمود میرافضلی ، به منظور ایجاد محیطی مناسب برای بحث و بررسی وضعیت تحولات علم و فناوری و بالاخص موضوعات مرتبط با موسسه تحقیقات واکسن و سرم سازی رازی تاسیس شده است. این وبلاگ ، به هیچ وجه سیاسی نیست و بر اساس مقررات نظام مقدس جمهوری اسلامی ایران برپا شده است و مسئولیت مطالب کلا بر عهده اینجانب است. رعایت ادب و انصاف در بیان مطالب و نقطه نظرات یک وِیژگی ممتاز محققین و پرسنل موسسه رازی است و امیدواریم همکاران گرامی بنده این خصلت نیکوی خود را به بهترین وجه نمایش دهند.
نویسنده: سید محمود میرافضلی
تاریخ: یکشنبه ۱ آبان ۱۳٩٠

چهارمین کنگره سالیانه واکسن BIT  در سال 2012 در کشور چین برگزار می شود. در این کنگره 400 نفر از مشهورترین چهر ه های واکسن سازی جهان حضور خواهند داشت و دهها مقاله و پوستر از آخرین یافته های تحقیقاتی این صنعت ارائه خواهد شد. همچنین موضوعات متنوعی از مسایل مرتبط با این صنعت شامل بازار فروش محصولات، تکنولوژیهای جدید، ماشین الات ، بازاریابی و ... در این کنگره مطرح می شود. در اینجا توجه شما را به مطالب صفحه نخست سایت این کنگره جلب می نمایم. همکاران و دوستانی که دلشان برای بازدید از دیوار چین لک زده است بشتابند که تاخیر موجب پشیمانی است!!!


 
 
 
 
 

BIT's Upcoming Events
 
 
   Highlights of the Conference

More than 400 presentations covering science, technology, business, economics and policy in

 

the field of vaccines by distinguished scientists and businessmen

Presentation of 200 posters and 100 exhibitions of new products and technologies to an

  audience of over 800 people

Round table discussions to create network and marketing opportunities for your business

Create a Harmony Environment for One-to-One Meetings with Key Decision Makers

Tech Tour to Famous Scenic Spots & Historical Sites in China


   Keynote Speakers
           
Dr. Rene Labatut,
Vice President Global Manufacturing Technology, Sanofi Pasteur Inc., France

Dr. William Strohl,
Vice President,
Biologics Research, Johnson & Johnson, USA

Dr. Raymond E. Spier,
President, the International Society for Vaccines, UK

           
Dr.Tilahun D. Yilma, Academician, National Academy of Science,USA

Reserved for Leading Scientist

   
           

   Renowned Speakers
           

John J. Trizzino.png

Dr. John J. Trizzino,
Chief Executive Officer, Immunovaccine Inc., USA

Alan Liss.jpg

Dr. Alan Liss,
Director, The U.S. Food and Drug Administration, USA

http://www.bitlifesciences.com/wcv2012/default_clip_image002_0008.jpg

Dr. Lorne Babiuk,
Vice-President, University of Alberta, Canada

           

Jerald Charles Sadoff.jpg

Dr. Jerald Charles Sadoff,
Chief Medical Officer, Crucell, The Netherlands

Leonard P. Ruiz.jpg

Dr. Leonard P. Ruiz,
President, International Medica Foundation, USA

Jay A. Berzofsky.jpg

Dr. Jay A. Berzofsky,
Chief, National Cancer Institute, USA

           

Jean-Yves Bonnefoy.jpg

Dr. Jean-Yves Bonnefoy,
Vice-President, Transgene S.A., France

Weiner Amy J.jpg

Dr. Weiner Amy J, Senior Program Officer, Bill & Melinda Gates Foundation, USA

http://www.bitlifesciences.com/wcv2012/default_clip_image002_0006.jpg

Dr. Deoki N. Tripathy,
Professor, University of Illinois, USA

           

Jean-Pierre Bizzari.jpg

Dr. Jean-Pierre Bizzari,
Senior Vice President, Celgene Corporation, USA

Dr. Richard Walker,
Director, PATH, USA

http://www.bitlifesciences.com/wcv2012/Wenle%20Xia.jpg

Dr. Wenle Xia,
Director, Duke University Medical Center, USA


Stephen Lockhart.jpg


Dr. Stephen Lockhart,

Senior Vice President, Emergent BioSolutions, UK

http://www.bitlifesciences.com/wcv2012/default_clip_image001_0011.jpg

Dr. Norman W. Baylor,
Director, CBER/FDA, USA

CherryJames.jpg

Dr. James D. Cherry,
Professor, University of California, Los Angeles, USA

           

Gil Price.jpg

Dr. Gil Price,
CEO, Drug Safety Solutions Ltd., USA

P106005.jpg

Dr. Bram Palache, Director, Abbott Biologicals, The Netherlands

http://www.bitlifesciences.com/wcv2012/Bryan%20Charleston.jpg

Dr. Bryan Charleston,
Investigator, Oxford University, UK

           

http://www.bitlifesciences.com/wcv2012/default_clip_image001_0010.jpg

Dr. Kelly McKee,
Vice President, Quintiles Transnational Corporation, USA

http://www.bitlifesciences.com/wcv2012/Peter%20L.%20Nara.jpg

Dr. Peter L. Nara, President, Biological Mimetics, Inc., USA

http://www.bitlifesciences.com/wcv2012/Pravin%20T.%20P.%20Kaumaya.jpg Dr. Richard L. Amoroso, Professor & Director, Noetic Advanced Studies Institute, USA
           

Nordgren%20compr.jpg

Dr. Nathalie Garcon,
Vice President, GlaxoSmithKline Biologicals, Belgium

Andrew A. Potter.jpg

Dr. Andrew A. Potter,
CEO, VIDO / InterVac, Canada

http://www.bitlifesciences.com/wcv2012/Pravin%20T.%20P.%20Kaumaya.jpg

Dr. Pravin T. P. Kaumaya,
Professor, The Ohio State University, USA

           

http://www.bitlifesciences.com/wcv2012/default_clip_image002_0005.jpg

Dr. Charles M. Y. Lim,
CEO Asia Pacific & China, BIA Separations, Austria

Jonathan J Liu.jpg

Dr. Jonathan J Liu,
Director of R&D, MedImmune, USA

http://www.bitlifesciences.com/wcv2012/default_clip_image002_0007.jpg

Dr. Michael Wallach,
Professor, University of Technology Sydney, Australia

http://www.bitlifesciences.com/wcv2012/default_clip_image002_0000.gif

Dr. Fredrik Sundberg,
Director, GE Healthcare, Sweden

http://www.bitlifesciences.com/wcv2012/Klaus%20Hermansen.jpg


Dr. Klaus Hermansen,

Senior Vaccine & Process Specialist, NNE Pharmaplan, Denmark

http://www.bitlifesciences.com/wcv2012/Dr.%20Zhen%20F.%20Fu.jpg

Dr. Zhen F. Fu,
Professor, University of Georgia, USA

Dr. Ben Adler, Director, Australian Research Council Centre of Excellence, Monash University, Australia Dr. Tammy R Beckham,
Director, Texas Veterinary Medical Diagnostic Laboratory, College Station, USA
Dr. Vadim Tsvetnitsky,
Senior Technical Officer, PATH, Vaccine Development Global Program, USA

   Program at a Glance
 

   Exhibition and Poster
 
WCV-2012 provides an ideal platform to showcase your novel technologies and products in China. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
 
 
  1. Meet international leaders in the field of vaccine science and technology
  2. Meet key decision makers from around the world
  3. Explore business opportunities in China and beyond
  4. Spotlight your technology and its commercial application
  5. Take advantage of the targeted audience at the conference and network in the exhibition hall

   Background of WCV-2011

BIT’s 3rd Annual World Vaccine Congress-2011(WCV-2011) was jointly held with the 4th Annual Protein and Peptide Conference, the 3rd Annual World Congress of BioSoft as well as the 3rd Annual Congress of Antibodies in Beijing which have attracted more than 1500 participants and 48 exhibitors from 56 countries have joined the conference and made the best out of it. More...

   Scenery of Tour
             
 

http://www.bitlifesciences.com/pepcon2011/pic/tour/jingdian%20-changcheng.jpg

 

http://www.bitlifesciences.com/pepcon2011/pic/tour/MuseumofQinTerra-cottaWarri.jpg

 
 
             
 

The Walls of Badaling

 

Terra Cotta Warriors and Horses

 
Tibet
 
             
 

http://www.bitlifesciences.com/pepcon2011/pic/tour/jingdian%20-gugong.jpg

 

http://www.bitlifesciences.com/pepcon2011/pic/tour/hqh-2.jpg

 

http://www.bitlifesciences.com/pepcon2011/pic/tour/苏州%20Suzhou%20garden.jpg

 
             
 

The Forbidden City

 

Hua Qing Hot Spring

 

Suzhou Garden

 
             
 
We welcome you to visit the tour webpage to learn more about the routes and prices. To join a tour please contact : muriel@bitworldtravel.com
 
 
 
Sunday Oct. 23, 19111
 

News Release

  • Abstracts Submission is Open

  • Call for Speakers

  • Call for Media Partners

  • Call for Collaborative Organizations


Concurrent Conference
 

BIT's 4th Annual International Congress of Antibodies Conference

Hosting Organizations
 

Information Research Center of International Talent, SAFEA
China Medicinal Biotech Association

Operating Organization


BIT World Congress (Dalian) Inc.

Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision


Official Travel Agent


BIT World Travel Service, Inc.

Supporting Organization

China Council for the Promotion of
International Trade
Dalian Sub-Council


Organization Participated

Emory University, USA

Institute Pasteur, France

Institute of Biotechnology and Antibiotics, Poland

Crucell, The Netherlands

Harvard Medical School, USA

Bill & Melinda Gates Foundation, USA

National Cancer Institute, USA

NIH, USA

Immune Targeting Systems (ITS) Ltd., UK

Institute of Epidemiology, Microbiology, and Infectious Diseases, Republic of Uzbekistan

National Institute of Infectious Disease, Japan

Sanofi Pasteur, France

Arbovax, Inc., USA

Institute Pasteur Korea, South Korea

New York Medical College, USA

International Medica Foundation, USA

Yeungnam University, South Korea

University of Gadjah Mada, Indonesia

Centro Superior de Investigación en Salud Pública (CSISP), Spain

Oxford University, UK

Quintiles Transnational Corporation, USA

Siriraj Hospital, Thailand

National Health Research Institutes, Taiwan

Novartis Vaccines & Diagnostics, Italy

Finlay Institute, Cuba

PATH, USA

Kuwait University, Kuwait

University of Colorado Denver, USA

Mahidol University, Thailand

Booz Allen Hamilton, USA

University of Naples Federico II, Italy

University of Technology Sydney, Australia

Rio de Janeiro, Brazil

Baylor College of Medicine, USA

 

Emory University, USA

Institute Pasteur, France

Institute of Biotechnology and Antibiotics, Poland

Crucell, The Netherlands

Harvard Medical School, USA

Bill & Melinda Gates Foundation, USA

National Cancer Institute, USA

NIH, USA

Immune Targeting Systems (ITS) Ltd., UK

Institute of Epidemiology, Microbiology, and Infectious Diseases, Republic of Uzbekistan

National Institute of Infectious Disease, Japan

Sanofi Pasteur, France

Arbovax, Inc., USA

Institute Pasteur Korea, South Korea

New York Medical College, USA

International Medica Foundation, USA

Yeungnam University, South Korea

University of Gadjah Mada, Indonesia

Centro Superior de Investigación en Salud Pública (CSISP), Spain

Oxford University, UK

Quintiles Transnational Corporation, USA

Siriraj Hospital, Thailand

National Health Research Institutes, Taiwan

Novartis Vaccines & Diagnostics, Italy

Finlay Institute, Cuba

PATH, USA

Kuwait University, Kuwait

University of Colorado Denver, USA

Mahidol University, Thailand

Booz Allen Hamilton, USA

University of Naples Federico II, Italy

University of Technology Sydney, Australia

Rio de Janeiro, Brazil

Baylor College of Medicine, USA

 

Exhibitors Participated

 
 
 
 
 
 
 
 
 
 
 
© 2010-2011 All right reserved for BIT World Congress (Dalian) Inc.
Contact Us : Tel : 0086-411-84799609, Fax : 0086-411-84796897
Feedback Form

برچسب ها
دوستان
ابزارک های وبلاگ